Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug-Reference-Cited by-同舟云学术

Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug

Published:2009-10 Issue:2 Volume:206 Page:375-382
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Lee Jung-Jin,Jin Yong-Ri,Yu Ji-Yeon,Munkhtsetseg Tudev,Park Eun-Seok,Lim Yong,Kim Tack-Joong,Pyo Myoung-Yun,Hong Jin Tae,Yoo Hwan-Soo,Kim Youngsoo,Yun Yeo-Pyo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. The role of the platelet in the pathogenesis of atherothrombosis;Steinhubl;Am J Cardiovasc Drugs,2005

2. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation;Chou;Blood,2004

3. The molecular basis of blood coagulation;Furie;Cell,1988

4. Biochemistry and physiology of blood coagulation;Mann;Thromb Haemost,1999

5. Platelets and thrombin generation;Monroe;Arterioscler Thromb Vasc Biol,2002

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail;Inflammation Research;2022-08-08

2. Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage;Stroke;2022-07

3. The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models;Frontiers in Pharmacology;2021-08-06

4. The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes;Current Opinion in Lipidology;2021-06-09

5. The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models;2021-01-11